Parashar is an accomplished healthcare executive with a demonstrated history of leadership in the medical device industry and public sector. He brings more than 30 years of health policy and market access experience to clients.Read Parashar Patel's full bio.
The Centers for Medicare & Medicaid Services (CMS) announced in March that it would allow health plans under Medicare Part D (the Medicare prescription drug benefit) to cover Wegovy and other weight-loss medications if they receive Food and Drug Administration (FDA) approval for an additional medically accepted indication. In Wegovy’s case, the FDA recently approved an additional...